Old Web
English
Sign In
Acemap
>
authorDetail
>
Eric Bartee
Eric Bartee
University of New Mexico
Cancer research
Myxoma virus
In vivo
Medicine
Immune system
5
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of Polyamine Biosynthesis Using Difluoromethylornithine Acts as a Potent Immune Modulator and Displays Therapeutic Synergy With PD-1-blockade.
2021
Journal of Immunotherapy
Parker C. Dryja
Carrie Fisher
Patrick M. Woster
Eric Bartee
Show All
Source
Cite
Save
Citations (0)
Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses.
2020
PLOS ONE
Erica B. Flores
Mee Y. Bartee
Eric Bartee
Show All
Source
Cite
Save
Citations (1)
Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication.
2020
Journal for ImmunoTherapy of Cancer
Erica B. Flores
Bülent Arman Aksoy
Eric Bartee
Show All
Source
Cite
Save
Citations (1)
160 TLR9-activated B cells imprint adoptively transferred CD8+ T cells with potent tumor immunity and persistence in vivo
2020
Journal for ImmunoTherapy of Cancer
Aubrey S. Smith
Hannah M. Knochelmann
Megan Wyatt
Connor J. Dwyer
Guillermo Rangel Rivera
Amalia Rivera Reyes
Jessica E. Thaxton
Eric Bartee
Mark P. Rubinstein
Bei Liu
Chrystal Paulos
Show All
Source
Cite
Save
Citations (0)
Decreasing the susceptibility of malignant cells to infection does not impact the overall efficacy of myxoma virus-based oncolytic virotherapy
2020
Molecular Therapy - Oncolytics
Erica B. Flores
Eric Bartee
Show All
Source
Cite
Save
Citations (0)
1